Total Testosterone: What This Blood Test Actually Measures

What Total Testosterone Actually Represents in Your Blood

Total testosterone is the sum of every testosterone molecule in a blood sample, regardless of whether that molecule is attached to a carrier protein or floating unbound. In adult males, roughly 65 to 68% of circulating testosterone rides on SHBG, a glycoprotein made primarily in the liver 1. Another 30 to 33% binds loosely to albumin. The remaining 2 to 3% circulates as free testosterone, the only fraction that can directly enter cells and activate androgen receptors 2.

This three-compartment model matters because each fraction behaves differently. SHBG-bound testosterone is tightly sequestered and considered biologically inactive during that binding. Albumin-bound testosterone dissociates easily at the capillary level, which is why clinicians sometimes group albumin-bound and free testosterone together under the label "bioavailable testosterone." The total testosterone assay does not distinguish between these compartments. It reports one number.

That single number, though, remains the recommended first-line test. The 2018 Endocrine Society Clinical Practice Guideline states: "We recommend measuring total testosterone using a reliable assay as the initial diagnostic test" for men with suspected androgen deficiency 3. The guideline specifies morning draws because testosterone follows a circadian rhythm, peaking between 7:00 and 10:00 AM, with levels dropping 20 to 25% by late afternoon.

How the Lab Measures It: Immunoassay vs. LC-MS/MS

Two methods dominate clinical laboratories. Standard immunoassays use antibodies that bind testosterone molecules in serum, then generate a measurable signal (chemiluminescence or electrochemiluminescence). These assays are fast and inexpensive. They also have a known weakness: cross-reactivity with structurally similar steroids like dihydrotestosterone (DHT) and androstenedione can inflate results, especially in women and children where circulating testosterone concentrations are low 4.

LC-MS/MS is the reference standard. It separates testosterone from other steroids by molecular weight and fragmentation pattern before quantifying the result. The CDC's Hormone Standardization Program (HoSt) has worked since 2010 to align commercial immunoassays with LC-MS/MS reference values, improving inter-laboratory agreement 5. A 2017 harmonization study across nine immunoassay platforms found that after HoSt calibration, mean bias dropped to within 6.4% of LC-MS/MS values for adult males 5.

For clinical purposes, most men with testosterone in the 400 to 700 ng/dL range will get comparable results from either method. Discrepancies matter most at the diagnostic boundary (around 264 to 300 ng/dL), in women, and in pediatric patients. If your result sits near a cutoff, ask your clinician whether the lab used immunoassay or mass spectrometry.

Normal Reference Ranges by Age and Sex

Reference ranges depend on the population sampled, the assay used, and the time of day. The Endocrine Society's Testosterone Trials (TTrials) established a harmonized reference range for men aged 19 to 39 without obesity: 264 to 916 ng/dL, based on LC-MS/MS measurements in the Framingham Heart Study and other cohorts 6.

Aging changes the picture. The Massachusetts Male Aging Study (MMAS), a longitudinal cohort of 1,709 men followed from 1987 to 2004, documented a decline of roughly 1.6% per year in total testosterone after age 30 7. SHBG rises with age, so the free fraction drops even faster, approximately 2 to 3% per year. By age 70, nearly 30% of men will have total testosterone below 300 ng/dL.

For adult females, no single guideline range dominates. Premenopausal women typically show total testosterone between 15 and 70 ng/dL, though the Endocrine Society cautions that "reliable testosterone assays for women remain a significant unmet medical need" 8. Post-menopausal levels often fall below 25 ng/dL.

In children and adolescents, testosterone should be measured by LC-MS/MS because immunoassays lack the sensitivity needed at low concentrations. Tanner staging correlates more tightly with pubertal testosterone rises than chronological age does.

Why Clinicians Order This Test

Total testosterone is the gatekeeper lab for four major clinical scenarios.

Suspected male hypogonadism. The Endocrine Society guideline recommends testing men who present with specific signs (reduced libido, erectile dysfunction, decreased spontaneous erections, breast discomfort, loss of body hair, small testes, infertility, or very low trauma fractures) along with nonspecific symptoms like fatigue and poor concentration 3. Two morning total testosterone values below 300 ng/dL, drawn on separate days, satisfy the biochemical criterion for testosterone deficiency. A single low value is not sufficient for diagnosis.

PCOS evaluation in women. The 2023 International Evidence-based Guideline for PCOS recommends total testosterone (or free testosterone calculated from total testosterone and SHBG) as part of the biochemical hyperandrogenism workup 9. Elevated total testosterone in a woman with oligo-anovulation meets one of the Rotterdam criteria.

TRT monitoring. For men already on testosterone therapy, trough total testosterone guides dose adjustments. The Endocrine Society recommends maintaining levels in the mid-normal range (450 to 600 ng/dL) and checking levels 3 to 6 months after initiation, then annually 3.

Screening before and during GLP-1 therapy. Observational data from the STEP trials show that rapid weight loss can transiently alter SHBG and total testosterone. Baseline and follow-up testing helps clinicians track whether testosterone normalizes as visceral fat decreases 10.

What Shifts Total Testosterone Up or Down

Understanding what moves this number helps you contextualize your result.

SHBG is the biggest confounder. Conditions that raise SHBG (hyperthyroidism, liver disease, aging, estrogen therapy, anticonvulsants) will push total testosterone upward even if free testosterone is unchanged. Conditions that suppress SHBG (obesity, insulin resistance, type 2 diabetes, nephrotic syndrome, exogenous androgens) will lower total testosterone relative to free testosterone 1. The European Male Ageing Study (EMAS), which measured hormones in 3,369 men aged 40 to 79, found that BMI was the strongest independent predictor of low total testosterone, stronger than age itself 11.

Dr. Shalender Bhasin, a lead author of the Endocrine Society's testosterone guideline, has stated: "Obesity is the most common cause of low total testosterone levels in men, and weight loss can partially reverse this decrease" 3.

Acute illness, opioid use, glucocorticoid therapy, and severe caloric restriction can all suppress the hypothalamic-pituitary-gonadal (HPG) axis and drive total testosterone below the reference range temporarily. These functional causes of low testosterone do not require TRT. They require treatment of the underlying condition.

How to Raise Total Testosterone Without Medication

Evidence-based strategies exist for men with borderline-low levels (250 to 400 ng/dL) who want to try lifestyle modification first.

Weight loss. A meta-analysis of 24 trials (N=1,787) published in the European Journal of Endocrinology found that diet-induced weight loss increased total testosterone by a mean of 2.9 nmol/L (approximately 84 ng/dL) in men with obesity 12. Bariatric surgery produced even larger increases, up to 8.7 nmol/L (approximately 251 ng/dL) at 12 months.

Resistance training. A 12-week resistance program in previously sedentary men raised total testosterone by 15 to 20% in multiple small trials, though gains depend on training intensity and baseline fitness 13.

Sleep optimization. One controlled study showed that restricting young men to 5 hours of sleep per night for one week reduced daytime testosterone by 10 to 15% 14. Normalizing sleep to 7 to 9 hours reversed the effect.

Vitamin D repletion. Men with 25-hydroxyvitamin D levels below 20 ng/mL who supplemented to achieve levels above 30 ng/mL showed modest testosterone increases (approximately 25% relative rise) in a 12-month randomized trial of 200 men 15.

These interventions work best in combination. None will rescue clinically significant primary hypogonadism (total testosterone consistently below 200 ng/dL with elevated LH), which typically requires TRT.

How to Lower Total Testosterone

Total testosterone suppression is a clinical goal in two main contexts: PCOS management in women and androgen deprivation therapy (ADT) in prostate cancer.

For women with PCOS, combined oral contraceptives (COCs) remain the first-line pharmacologic approach. COCs increase hepatic SHBG production, which lowers free and total testosterone. Spironolactone at 50 to 200 mg/day adds direct androgen receptor blockade 9. Weight loss in women with PCOS and obesity reduces insulin resistance, lowers SHBG-independent androgen production from the ovaries and adrenals, and can lower total testosterone by 10 to 20% 16.

For prostate cancer, GnRH agonists (leuprolide, goserelin) or antagonists (degarelix, relugolix) suppress testicular testosterone production to castrate levels (<50 ng/dL). Relugolix, the first oral GnRH antagonist approved for advanced prostate cancer, achieved castrate testosterone in 96.7% of men by day 29 in the HERO trial (N=934) 17.

When Total Testosterone Alone Is Not Enough

There are clinical scenarios where total testosterone gives an incomplete or misleading picture.

In men with obesity and low SHBG, total testosterone may read low while free testosterone remains adequate. The reverse occurs in older men or those on estrogen: SHBG rises, total testosterone looks normal, but free testosterone is deficient. The Endocrine Society guideline recommends measuring free testosterone (calculated from total testosterone, SHBG, and albumin using the Vermeulen equation) when total testosterone falls between 200 and 400 ng/dL or when SHBG abnormalities are suspected 3.

Equilibrium dialysis is the gold standard for free testosterone measurement, but it is available at very few reference laboratories. Calculated free testosterone using total testosterone, SHBG, and albumin correlates well with dialysis-measured values in most clinical settings 18.

LH and FSH should accompany total testosterone in the initial workup. High LH with low testosterone indicates primary hypogonadism (testicular failure). Low or inappropriately normal LH with low testosterone points to secondary hypogonadism (hypothalamic or pituitary dysfunction), which requires MRI of the sella turcica and prolactin measurement to rule out a pituitary adenoma 3.

Pre-Test Preparation: Getting an Accurate Result

The single most common source of a falsely low testosterone result is afternoon blood draws. Testosterone nadir occurs between 2:00 and 8:00 PM, when levels may be 20 to 35% lower than morning peak values 19. The circadian variation diminishes with age but does not disappear.

Fast for at least 8 hours before the draw. A 2014 study of 3,000 men in the EMAS cohort demonstrated that glucose ingestion acutely suppressed total testosterone by 25% for up to 2 hours 20.

Avoid strenuous exercise in the 24 hours before testing. Acute high-intensity exercise can transiently raise testosterone by 15 to 30%, while prolonged endurance exercise (marathon training) can suppress it. Hold biotin supplements for at least 72 hours if the lab uses a biotin-streptavidin immunoassay, as exogenous biotin causes assay interference.

For TRT patients on injectable testosterone cypionate or enanthate, draw trough levels 24 to 48 hours before the next injection. For transdermal testosterone, draw 4 to 6 hours after application to capture steady-state absorption.